Novel Nonsymmetrical 1,4-Dihydropyridines as Inhibitors of Nonsymmetrical MRP-Efflux Pumps for Anticancer Therapy

Cancer is a strong global burden with increasing numbers of diseases and ongoing anticancer drug resistance. The number of structurally novel anticancer drugs is strongly limited. They cause high costs for the social health systems. Most critical so-called multidrug resistances (MDR) are caused by t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreutzer, David, Ritter, Christoph A., Hilgeroth, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407134/
https://www.ncbi.nlm.nih.gov/pubmed/32660005
http://dx.doi.org/10.3390/ph13070146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407134/
https://www.ncbi.nlm.nih.gov/pubmed/32660005
http://dx.doi.org/10.3390/ph13070146

Ejemplares similares